The specific role of O6-methylguanine-DNA methyltransferase inhibitors in cancer chemotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The specific role of O6-methylguanine-DNA methyltransferase inhibitors in cancer chemotherapy
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume -, Issue -, Pages -
Publisher
Future Science, LTD
Online
2018-07-13
DOI
10.4155/fmc-2018-0069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- S-phase Specific Downregulation of Human O 6 -Methylguanine DNA Methyltransferase (MGMT) and its Serendipitous Interactions with PCNA and p21 cip1 Proteins in Glioma Cells
- (2018) AGM Mostofa et al. NEOPLASIA
- The potential of combi-molecules with DNA-damaging function as anticancer agents
- (2017) Guohui Sun et al. Future Medicinal Chemistry
- Synthesis and Antitumor Activity Evaluation of a Novel Combi-nitrosourea Prodrug: BGCNU
- (2017) Yameng Wang et al. ACS Medicinal Chemistry Letters
- Evaluation of O6-Benzylguanine−Potentiated Topical Carmustine for Mycosis Fungoides
- (2017) Joselin D. Tacastacas et al. JAMA Dermatology
- Chemoproteomics-Enabled Discovery of a Potent and Selective Inhibitor of the DNA Repair Protein MGMT
- (2016) Chao Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthesis and antitumor activity evaluation of a novel combi-nitrosourea prodrug: Designed to release a DNA cross-linking agent and an inhibitor of O6-alkylguanine-DNA alkyltransferase
- (2016) Guohui Sun et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Advanced interstitial chemotherapy for treating malignant glioma
- (2016) Yuan-Yun Tseng et al. Expert Opinion on Drug Delivery
- Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking
- (2016) Guohui Sun et al. MOLECULES
- The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
- (2015) Michael Goldstein et al. Annual Review of Medicine
- Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression
- (2015) YACHAO ZHAO et al. Molecular Medicine Reports
- Investigations on the Effect of O6-Benzylguanine on the Formation of dG-dC Interstrand Cross-Links Induced by Chloroethylnitrosoureas in Human Glioma Cells Using Stable Isotope Dilution High-Performance Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry
- (2014) Guohui Sun et al. CHEMICAL RESEARCH IN TOXICOLOGY
- β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: An update
- (2014) Isabelle Tranoy-Opalinski et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Comparative investigation of the DNA inter-strand crosslinks induced by ACNU, BCNU, CCNU and FTMS using high-performance liquid chromatography–electrospray ionization tandem mass spectrometry
- (2014) Lijiao Zhao et al. INTERNATIONAL JOURNAL OF MASS SPECTROMETRY
- Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation
- (2014) Patrick T. Grogan et al. INVESTIGATIONAL NEW DRUGS
- Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage
- (2013) A. Paranjpe et al. CARCINOGENESIS
- Hypoxia-Selective O6-Alkylguanine-DNA Alkyltransferase Inhibitors: Design, Synthesis, and Evaluation of 6-(Benzyloxy)-2-(aryldiazenyl)-9H-purines as Prodrugs of O6-Benzylguanine
- (2013) Rui Zhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- HIF-1α inhibition sensitizes pituitary adenoma cells to temozolomide by regulating MGMT expression
- (2013) WENNA CHEN et al. ONCOLOGY REPORTS
- Phase I Clinical Trial of O6-Benzylguanine and Topical Carmustine in the Treatment of Cutaneous T-Cell Lymphoma, Mycosis Fungoides Type
- (2012) Narin Apisarnthanarax et al. ARCHIVES OF DERMATOLOGY
- Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase
- (2012) Rui Zhu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- F2A sequence linking MGMTP140K and MDR1 in a bicistronic lentiviral vector enables efficient chemoprotection of haematopoietic stem cells
- (2012) P Maier et al. CANCER GENE THERAPY
- DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
- (2012) Wynand P. Roos et al. CANCER LETTERS
- A Strategy for Selective O6-Alkylguanine-DNA Alkyltransferase Depletion Under Hypoxic Conditions
- (2012) Philip G. Penketh et al. Chemical Biology & Drug Design
- A density functional theory investigation on the formation mechanisms of DNA interstrand crosslinks induced by chloroethylnitrosoureas
- (2012) Li-Jiao Zhao et al. INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY
- Comparative theoretical investigation of the formation of DNA interstrand crosslinks induced by two kinds ofN-nitroso compounds: nitrosoureas and nitrosamines
- (2012) Lijiao Zhao et al. JOURNAL OF PHYSICAL ORGANIC CHEMISTRY
- Towards more specific O6-methylguanine-DNA methyltransferase (MGMT) inactivators
- (2011) Sergio Lopez et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours
- (2011) H A Tawbi et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Multifaceted Roles of Alkyltransferase and Related Proteins in DNA Repair, DNA Damage, Resistance to Chemotherapy, and Research Tools
- (2011) Anthony E. Pegg CHEMICAL RESEARCH IN TOXICOLOGY
- 6-Carboxyfluorescein and structurally similar molecules inhibit DNA binding and repair by O6-alkylguanine DNA alkyltransferase
- (2011) Manana Melikishvili et al. DNA REPAIR
- 4-Nitrobenzyloxycarbonyl Derivatives ofO6-Benzylguanine as Hypoxia-Activated Prodrug Inhibitors ofO6-Alkylguanine-DNA Alkyltransferase (AGT), Which Produces Resistance to Agents Targeting theO-6 Position of DNA Guanine
- (2011) Rui Zhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study
- (2011) Katherine E. Warren et al. JOURNAL OF NEURO-ONCOLOGY
- Quantification of meCCNU-induced dG-dC crosslinks in oligonucleotide duplexes by liquid chromatography/electrospray ionization tandem mass spectrometry
- (2011) Baoqing Bai et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Targeting O 6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy
- (2010) Bernd Kaina et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates
- (2010) Brian C. Beard et al. JOURNAL OF CLINICAL INVESTIGATION
- A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma
- (2009) R F Kefford et al. BRITISH JOURNAL OF CANCER
- Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme
- (2009) J. A. Quinn et al. CLINICAL CANCER RESEARCH
- Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O6-methylguanine-DNA methyltransferaseP140K
- (2009) P Maier et al. GENE THERAPY
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
- (2009) Jennifer A. Quinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Topologies of Complexes Containing O6-Alkylguanine–DNA Alkyltransferase and DNA
- (2009) Claire A. Adams et al. JOURNAL OF MOLECULAR BIOLOGY
- A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
- (2008) O A Khan et al. BRITISH JOURNAL OF CANCER
- Degradation of BRCA2 in Alkyltransferase-Mediated DNA Repair and Its Clinical Implications
- (2008) S. Philip et al. CANCER RESEARCH
- Structure-Based Discovery of Novel Non-nucleosidic DNA Alkyltransferase Inhibitors: Virtual Screening and in Vitro and in Vivo Activities
- (2008) Federico M. Ruiz et al. Journal of Chemical Information and Modeling
- Substitution of Aminomethyl at the Meta-Position Enhances the Inactivation ofO6-Alkylguanine-DNA Alkyltransferase byO6-Benzylguanine
- (2008) Gary T. Pauly et al. JOURNAL OF MEDICINAL CHEMISTRY
- DNA alkylation products formed by 1-(2-chloroethyl)-1-nitrosourea as molecular dosimeters of therapeutic response
- (2008) William J. Bodell JOURNAL OF NEURO-ONCOLOGY
- Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: A Children's Oncology Group study
- (2007) Denise M. Adams et al. PEDIATRIC BLOOD & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started